Prof. Gagandeep Kang, the current Executive Director of the DBT funded Translational Health Science & Technology Institute has joined the governance of the COVID19 Clinical Research Consortium. She has joined as a member of the Facilitation Committee of the initiative. With this, THSTI becomes a member of this global coalition (https://covid19crc.org/members/). The only other member institution from India is the Christian Medical College, Vellore.

The COVID-19 Clinical Research Coalition aims to accelerate clinical research for COVID-19 in resource-limited settings. The coalition brings together institutions and groups working to fast-track research that will provide evidence on COVID-19 prevention, diagnosis, and case management in such settings. More details can be found on its website www.covid19crc.org. 

The Facilitation Committee, as the governance body of the Coalition, will make decisions on the governance, funding, and activities of the COVID-19 Clinical Research Coalition and guide the work of the secretariat.  The Committee consists of a diverse group of eight to ten individuals with distinguished leadership in the field of science and broad experience related to clinical research and the pandemic response, and will include, to ensure continuity, representatives the three instigating organizations (MORU, DNDi, and IDDO) who facilitated the launch and initial design of the Coalition.

More details can be found in this commentary on Lancet:

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30798-4/fulltext.